SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-18-052951
Filing Date
2018-02-22
Accepted
2018-02-22 06:17:34
Documents
86
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d507705d10k.htm 10-K 1422074
2 EX-23.1 d507705dex231.htm EX-23.1 1673
3 EX-31.1 d507705dex311.htm EX-31.1 10075
4 EX-31.2 d507705dex312.htm EX-31.2 10092
5 EX-32.1 d507705dex321.htm EX-32.1 3365
6 EX-32.2 d507705dex322.htm EX-32.2 3368
13 GRAPHIC g507705g04p21.jpg GRAPHIC 105905
  Complete submission text file 0001193125-18-052951.txt   6331057

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT achn-20171231.xml EX-101.INS 1097294
8 XBRL TAXONOMY EXTENSION SCHEMA achn-20171231.xsd EX-101.SCH 62621
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE achn-20171231_cal.xml EX-101.CAL 72486
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE achn-20171231_def.xml EX-101.DEF 383747
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE achn-20171231_lab.xml EX-101.LAB 489815
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE achn-20171231_pre.xml EX-101.PRE 448649
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Filer) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33095 | Film No.: 18630494
SIC: 2834 Pharmaceutical Preparations